Showing results (141-150 of 179) with videos related to

Sort By:
Pageof 18
Nature Communications|March 1, 2014
Differential affinity of FLIP and procaspase 8 for FADD's DED binding surfaces regulates DISC assemblyJ Majkut, M Sgobba, C Holohan, et al.
Molecular Cancer Therapeutics|November 7, 2020
BRCA1/MAD2L1 Deficiency Disrupts the Spindle Assembly Checkpoint to Confer Vinorelbine Resistance in MesotheliomaSara Busacca, Laura O'Regan, Anita Singh, et al.
European Journal of Cancer (Oxford, England : 1990)|June 19, 2012
Response to chemotherapy is predictive in relation to longer overall survival in an individual patient combined-analysis with pleural mesotheliomaJaine K Blayney, Giovanni L Ceresoli, Bruno Castagneto, et al.
BMJ Open Respiratory Research|March 14, 2018
BTS guideline for the investigation and management of malignant pleural mesotheliomaIan Woolhouse, Lesley Bishop, Liz Darlison, et al.
The Lancet. Oncology|February 14, 2022
Abemaciclib in patients with p16ink4A-deficient mesothelioma (MiST2): a single-arm, open-label, phase 2 trialDean A Fennell, Amy King, Seid Mohammed, et al.
The Lancet. Oncology|July 22, 2017
Tremelimumab as second-line or third-line treatment in relapsed malignant mesothelioma (DETERMINE): a multicentre, international, randomised, double-blind, placebo-controlled phase 2b trialMichele Maio, Arnaud Scherpereel, Luana Calabrò, et al.
The Lancet. Oncology|May 19, 2022
EZH2 inhibitor tazemetostat in patients with relapsed or refractory, BAP1-inactivated malignant pleural mesothelioma: a multicentre, open-label, phase 2 studyMarjorie G Zauderer, Peter W Szlosarek, Sylvestre Le Moulec, et al.
Scientific Reports|April 2, 2021
Transcriptional perturbation of protein arginine methyltransferase-5 exhibits MTAP-selective oncosuppressionSara Busacca, Qi Zhang, Annabel Sharkey, et al.
The Lancet. Oncology|October 17, 2021
Nivolumab versus placebo in patients with relapsed malignant mesothelioma (CONFIRM): a multicentre, double-blind, randomised, phase 3 trialDean A Fennell, Sean Ewings, Christian Ottensmeier, et al.
Nature|December 9, 2021
Non-genetic determinants of malignant clonal fitness at single-cell resolutionKatie A Fennell, Dane Vassiliadis, Enid Y N Lam, et al.
Pageof 18